Company intelligence / Profile preview

Sylphar

Deurle, East Flanders, Belgium

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Sylphar is a Belgium-based consumer healthcare company that develops and markets innovative oral care and skin care products. The company is best known for its global brands, including iWhite for teeth whitening, Remescar for immediate skin correction, and Herpatch for cold sore treatment. Sylphar focuses on bringing clinically proven, easy-to-use products to the over-the-counter (OTC) market. In 2021, the company was acquired by Karo Healthcare to strengthen its presence in the European consumer health sector. Its products are distributed in over 50 countries worldwide through pharmacies and retail channels.

Therapeutic areas: OphthalmologyInfectious DiseasesOtherDermatology
Modalities: Small moleculeCosmeticDevice
Industry: Biotech

Beyond the preview

Go deeper on Sylphar.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sylphar.

Explore the full profile